ArticlePloS one2014

Dasatinib targets B-lineage cells but does not provide an effective therapy for myeloproliferative disease in c-Cbl RING finger mutant mice.

Johanna M Duyvestyn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.